As infectious complications from blood transfusion have decreased because of improved
donor questionnaires and sophisticated infectious disease blood screening, noninfectious …

Context.—Serious noninfectious complications are far more likely to occur than viral disease
transmission from blood component transfusion. Objective.—To compile a comprehensive …

As screening for transfusion-associated infections has improved, non-infectious
complications of transfusion now cause the majority of morbidity and mortality associated …

Blood transfusions are life-saving therapies; however, they can result in adverse events that
can be infectious or, more commonly, noninfectious. The most common noninfectious …

Substantial advances have been achieved in blood safety during the last 20 years,
particularly for transfusion-transmitted viral infections. Currently, the most serious known …

Blood transfusion is considered safe when the infused blood is tested using state of the art
viral assays developed over the past several decades. Only rarely are known viruses like …

Plasma utilization has increased over the past two decades, and there is a growing concern
that many plasma transfusions are inappropriate. Plasma transfusion is not without risk, and …

Transfusion reactions are common occurrences, and clinicians who order or transfuse blood
components need to be able to recognize adverse sequelae of transfusion. The differential …

Blood transfusions have been the cornerstone of life support since the introduction of the
ABO classification in the 20th century. The physiologic goal is to restore adequate tissue …

Each year, more than 4 million patients receive a blood transfusion in the United States to
control symptoms associated with anemia, coagulopathy, thrombocytopenia, or some …